Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000636
Filing Date
2023-04-11
Accepted
2023-04-11 16:31:39
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS bmrn4152191-defa14a.htm DEFA14A 33604
2 GRAPHIC logo.jpg GRAPHIC 14893
3 GRAPHIC bmrn4152191-defa14ax1x6.jpg GRAPHIC 2592
4 GRAPHIC bmrn4152191-defa14ax1x1.jpg GRAPHIC 71777
5 GRAPHIC bmrn4152191-defa14ax1x2.jpg GRAPHIC 5163
6 GRAPHIC bmrn4152191-defa14ax1x3.jpg GRAPHIC 8256
7 GRAPHIC bmrn4152191-defa14ax1x4.jpg GRAPHIC 12438
8 GRAPHIC bmrn4152191-defa14ax1x5.jpg GRAPHIC 6871
9 GRAPHIC bmrn4152191-defa14ax2x4.jpg GRAPHIC 42389
10 GRAPHIC bmrn4152191-defa14ax2x1.jpg GRAPHIC 1098
11 GRAPHIC bmrn4152191-defa14ax2x3.jpg GRAPHIC 1109
  Complete submission text file 0001308179-23-000636.txt   265602
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 23813724
SIC: 2834 Pharmaceutical Preparations